Albert Heijn Paracetamol

Quick links

Choose a section

Quick links to important sections

Advertisements

Albert Heijn Paracetamol

Advertisements
Advertisements

Overview of Albert Heijn Paracetamol

Quick Facts

Property Description
Active ingredient Paracetamol (Acetaminophen)
Form Oral Solid Tablet or Capsule
Pharmacological class Analgesic and Antipyretic
Common use Symptomatic relief of pain and fever
Origin Synthetic Organic Compound

What Type of Medicine is Albert Heijn Paracetamol?

The Albert Heijn Paracetamol product is defined by its sole active ingredient, Paracetamol, which is internationally recognized under the systematic nomenclature Acetaminophen. This compound is categorized as both an analgesic and antipyretic, functions that are supported by wide pharmacological recognition.

This medicine belongs to the chemical group of para-aminophenol derivatives and is a synthetic organic compound. This classification confirms its distinction from non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, because Paracetamol provides pain and fever relief without exhibiting significant anti-inflammatory effects. As a product under the established Albert Heijn brand, it is a readily available, over-the-counter (OTC) option for general discomfort management.

Active Ingredient, Composition, and Form

The preparation is a single-ingredient medicine, utilizing only Paracetamol as the active substance. The active chemical substance itself is C8H9NO2. In its typical solid pharmaceutical preparation, the active powder is integrated with standard excipients to form an oral tablet or capsule designed for oral administration and efficient absorption.

The General Purpose and Core Benefit

The core benefit of taking this medicine is to achieve fundamental symptomatic relief for the patient, often used for managing common discomfort or fever. Paracetamol operates as an effective analgesic by influencing pain perception pathways, and as an antipyretic by modulating the body's thermoregulatory center. This dual action, which is clinically recognized for its central effect, defines the general purpose of the product: to offer focused relief from common discomfort and temperature elevation.

Regulatory References

  1. MedlinePlus Drug Information
  2. PubChem Chemical Compound Summary
  3. PMC Review of Acetaminophen Mechanisms
Advertisements

What side effects are possible with Albert Heijn Paracetamol?

Possible side effects and safety information

The safety profile for Albert Heijn Paracetamol (Acetaminophen) is formally documented in government regulatory sources, which classify adverse events primarily by frequency and the physiological system affected. This information focuses on defining the types of possible side effects rather than providing clinical advice.


Adverse Reaction Classification

Official regulatory documents classify adverse reactions based on their estimated occurrence. Many severe effects are classified as Rare or Very Rare, meaning they may affect less than 1 in 1,000 or less than 1 in 10,000 individuals, respectively. Some serious reactions are of Not Known frequency (cannot be estimated from available data).

Key systems where adverse reactions are documented include the Hepatobiliary Disorders (liver), Immune System Disorders, Blood and Lymphatic System Disorders, and Skin and Subcutaneous Tissue Disorders.


Serious Adverse Reactions

The most significant safety concerns highlighted in regulatory labeling are severe, including Severe Hepatic Injury (Hepatotoxicity), which carries the risk of liver failure, and Serious Skin Reactions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Severe Hypersensitivity reactions, including Anaphylactic shock, are also officially documented.


Safety Constraints and Special Populations

Safety notes explicitly state that the risk of liver damage is most commonly associated with exceeding the maximum total daily dose. Caution is officially documented for use in individuals with pre-existing conditions, particularly Hepatic Impairment and Severe Renal Impairment. Additionally, regulatory texts note that clinical signs of liver damage typically appear after a specific duration of exposure, peaking after four to six days of use. Prolonged daily use may also affect the anticoagulant action of medicines like warfarin.

Advertisements

Overdose and Emergency Response

Immediate medical advice must be sought in the event of any known or suspected overdose, even if the person appears well. This action is critical because the earliest documented manifestations, which include nausea, vomiting, pallor, and general malaise, may not fully reflect the progression toward severe toxicity. Urgent hospital referral for immediate medical attention is a mandatory regulatory requirement.

Regulatory documents classify overdose as a significant risk for severe, life-threatening outcomes, primarily hepatic necrosis and acute liver failure. Other serious documented complications include acute renal failure, metabolic acidosis, and the development of coagulation defects. The full scope of injury, signaled by later signs such as jaundice, confusion, or right upper quadrant tenderness, can progress up to 72 hours following ingestion.

The treatment of choice is the specific antidote, N-acetylcysteine. For maximal protective effect against severe injury, this treatment must be initiated within the critical window of the first eight hours following ingestion. Risk assessment in a hospital setting requires measuring the plasma concentration against a treatment nomogram, as reliance solely on clinical status is unreliable. Regulatory labeling identifies increased risk for severe injury in patients with underlying liver disease, chronic alcoholism, or conditions resulting in depleted glutathione stores.

Advertisements

Therapeutic Uses of Albert Heijn Paracetamol

The medication is commonly used to help with the management of symptoms related to physical discomfort and systemic imbalance (fever). The medicine is classified as both an analgesic (pain reliever) and an antipyretic (fever reducer).


Easing Mild to Moderate Pain and Discomfort

This medication is commonly used for symptomatic analgesia, addressing symptoms related to physical discomfort that may interfere with daily functioning. It is applied when appropriate for symptom clusters such as tension headaches, muscle aches, backache, toothache, and menstrual pain (dysmenorrhea). The key therapeutic benefit provides support that helps ease the overall symptom burden, which contributes to easing the impact of symptoms that create noticeable physiological strain.


Managing Elevated Body Temperature (Fever)

Albert Heijn Paracetamol is commonly used to help with the management of symptoms related to systemic imbalance, such as elevated body temperature (fever). It is applied across therapeutic domains involving heightened physiological activity, such as colds, flu, and other viral infections, as well as fever that may follow vaccination. This supports patients during difficult episodes by easing distress and may help patients cope more steadily with symptom fluctuations.


Quick Fact: Relief for Pain and Fever

Property Description
Primary Domain Used for managing symptoms related to physical discomfort.
Secondary Domain Used for managing symptoms related to systemic imbalance (fever).
Common Scenarios Headaches, colds and flu symptoms, minor muscle pain, post-vaccination fever.
Patient Benefit Supports the patient during difficult episodes.

Regulatory References

  1. NIH MedlinePlus Drug Information overview
Advertisements

Eligibility and Restrictions for Use

Official Regulatory Eligibility Status

This section defines eligibility for Paracetamol/Acetaminophen strictly according to government regulatory labeling, identifying who is officially permitted or prohibited from using the medicine.

Population Status Regulatory Classification Defining Conditions
Absolute Contraindications Contraindicated Known hypersensitivity to the drug or excipients; severe hepatic impairment or severe active liver disease.
Conditional Use / Caution Use with Caution Non-severe hepatic impairment, severe renal impairment (CLcr le 30 mL/min), chronic alcoholism, chronic malnutrition, or severe hypovolemia.

Age-Based Approval Status Use is established for adults and adolescents. For many tablet formulations, use is not recommended for children under 10 years of age. Regulatory documents note that effectiveness is not established in pediatric patients younger than 2 years. Use in the geriatric population is established without routine dose modification.

Reproductive Eligibility Official labeling permits use during pregnancy if clinically needed, but specifies use at the lowest effective dose for the shortest possible time. Use is considered compatible during lactation.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific interaction patterns for Paracetamol (Acetaminophen) based on pharmacokinetic and pharmacodynamic effects.

Interaction Type Interacting Substances / Conditions
Contraindicated Combinations Other Paracetamol-containing products (due to risk of hepatic overexposure) and Severe Hepatic Impairment (patients with severe active liver disease).
Pharmacodynamic Enhancement Warfarin and other Coumarins. Prolonged, regular daily use is documented to enhance the anticoagulant effect, increasing the International Normalized Ratio (INR).
Metabolic Interactions Hepatic Enzyme Inducers (e.g., Carbamazepine, Rifampin, St. John's Wort). These are documented to increase the potential for liver damage from paracetamol, especially in the setting of overdose.
Absorption Rate Modification Metoclopramide and Domperidone (increase absorption speed), while Cholestyramine (reduces absorption).

Co-administration with enzyme-inducing substances, including chronic consumption of three or more alcoholic drinks per day, is officially stated to increase the risk of severe liver damage. Further documented interactions include an increased risk of toxicity with Busulfan and potentiation of hematological toxicity with Zidovudine. For individuals with severe renal impairment or Glutathione deficiency, cautions regarding interaction severity are officially noted.

Advertisements

Mechanism of Action

Central Modulation of Nociception and Thermoregulation

This drug acts primarily in the central nervous system (brain and spinal cord) by weakly inhibiting certain Cyclooxygenase (COX) enzymes. This action limits the formation of key chemical messengers, called prostaglandins, which are involved in promoting the upward setting of the body's thermal set-point and the sensitization of nociceptive signals. This action promotes the downward regulation of the body's thermal set-point and a functional reduction in the transmission of nociceptive signals.

Contribution via Secondary Neurotransmitter Pathways

The drug’s mechanism includes contribution from its active metabolite, AM404. This metabolite engages the Endocannabinoid and Serotonergic pathways, which are components of the descending pain inhibitory system. This engagement with the serotonergic and endocannabinoid pathways increases the central modulation of nociceptive pathways, thereby functionally amplifying endogenous mechanisms for signal inhibition.

Mechanistic Specificity and Constraints

The mechanism exhibits constrained activity within peripheral tissues (outside the central nervous system), which is influenced by local biochemical conditions. This results in the mechanism having limited effect on peripheral prostaglandin synthesis and low modulation of peripheral inflammatory pathways. The physiological consequences are thus primarily restricted to thermoregulation and central nociception.

Advertisements

Dosage and Administration Information

Instruction Map: How to use Albert Heijn Paracetamol — Administration Guidelines

Administration Scope

Instruction Entity Detail
Route of administration Oral administration using the tablet or capsule form, which is the designated route for this product.
Dosing schedule Standard Single Dose: 500 mg to 1000 mg (1 g). Maximum Daily Dose: The total amount must not exceed 4000 mg (4 g) over a 24-hour period.
Timing in relation to meals The medication may be taken with or without food.
Preparation requirements The oral solid form must be swallowed whole with a drink of water or other liquid.
Age-group administration rules The standard regimen is for adults and adolescents 16 years and over. Pediatric use requires weight-based dosing, typically 10–15 mg/kg per dose.
Missed-dose rules If a scheduled dose is missed, it should be taken when remembered, provided that the minimum 4-hour interval before the next dose can still be observed. A missed dose must not be doubled.
Special procedural conditions Hepatic or Renal Adjustment: The dose or the dosing interval must be modified in cases of severe hepatic or renal impairment, as per prescribing guidelines.

Instruction Classifications

Classification Detail
Administration method type Oral
Frequency pattern As-needed (intermittent) use, strictly governed by the required minimum time separation between doses.
Basis of application Consistent with established prescribing information.
Use-context constraints Short-term use, strictly limited by absolute constraints on single and total daily dosage.

Resulting Procedural Structure

Standard step sequence:

  • Administer the prescribed 500 mg to 1000 mg dose orally.
  • Wait a minimum of four hours before taking any subsequent dose.
  • Ensure the total amount consumed does not exceed the 4000 mg maximum within the 24-hour procedural cycle.

Connection to the overall use protocol

The guidelines establish an intermittent, oral administration protocol that is strictly governed by numerical constraints on dose and frequency. This structure mandates adherence to a minimum 4-hour time interval and an absolute 4000 mg maximum daily limit. The protocol ensures standardized application of the medicine while allowing for necessary procedural modifications in specific populations.

Advertisements

Recent Clinical Evidence

Albert Heijn Paracetamol: Recent Clinical Evidence

Clinical evidence regarding the compound paracetamol (acetaminophen) primarily focuses on its effectiveness in reducing pain (analgesia) and fever (antipyresis).


Evaluation of Efficacy in Pain and Fever

Studies have consistently demonstrated the effect of paracetamol in managing fever in both children and adults. Its efficacy as an antipyretic agent is considered well-established, with effects generally observed within three hours in febrile patients.

For pain relief, the evidence quality varies by condition:

  • Acute Pain: High-quality evidence supports paracetamol's use for mild-to-moderate acute pain, such as post-operative pain and tension-type headaches. Some studies indicate a benefit over placebo, though the magnitude of the effect is often considered modest.
  • Chronic Pain: The evidence regarding the long-term effectiveness of paracetamol for chronic conditions is often considered limited or mixed. For instance, strong evidence suggests it is not effective for relieving acute low back pain, and benefits for conditions like knee or hip osteoarthritis have been described as modest in recent systematic reviews.

Research on Tolerability and Safety

Paracetamol is widely regarded as a suitable first-line option for acute pain in many patient populations due to a generally favorable tolerability profile at recommended doses. Research has explored adverse events, noting that the frequency of gastrointestinal side effects is substantially lower compared to non-steroidal anti-inflammatory drugs (NSAIDs).

Key safety research findings include:

  • Liver Enzymes: Transient elevation of liver enzyme levels was more frequently observed in participants receiving repeated doses of paracetamol compared to placebo in some spinal pain trials, though the clinical significance of this change is uncertain.
  • Overdose Risk: Research strongly highlights the risk of hepatotoxicity (liver damage) when the recommended maximum daily dose is exceeded, underscoring the importance of careful dosing.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Albert Heijn Paracetamol (FAQ)


Q: What are the most common side effects associated with paracetamol use?

Adverse event reporting indicates that common side effects are reported to involve the digestive system. These frequently reported events include nausea, vomiting, abdominal pain, diarrhea, and constipation.


Q: Does taking paracetamol with food change how quickly it works?

Official product information notes that administration with food may delay the time required for the active ingredient to reach its maximum concentration in the bloodstream. The medicine may still be taken with or without food.


Q: Why do official guidelines emphasize sticking to the lowest effective dose of paracetamol?

Official warnings emphasize that exceeding the recommended maximum daily dose is associated with a documented risk of serious liver injury (hepatotoxicity). The emphasis on using the lowest effective dose for the shortest time reflects this core safety concern regarding total intake over a 24-hour period.


Q: What are the signs of a potential allergic reaction to paracetamol?

Severe hypersensitivity reactions are officially documented possibilities. Symptoms described in official safety information include severe skin reactions, such as skin reddening, blisters, and rashes. More severe signs may include wheezing or swelling of the face, lips, or tongue.


Q: Is it normal to feel a mild stomach upset after taking paracetamol?

Gastrointestinal symptoms are listed among the reported adverse events for paracetamol. These effects can include mild stomach discomfort such as nausea, vomiting, and abdominal pain.


Q: Does using paracetamol affect the immune system?

Regulatory documents classify Immune System Disorders as a system where adverse reactions have been reported. These documented adverse reactions include severe events such as anaphylactic shock and other forms of hypersensitivity.


Q: What is the purpose of the filler ingredients in paracetamol tablets?

Official documentation acknowledges the use of excipients, often referred to as inactive or filler ingredients. These are necessary to form the tablet or capsule structure and support the product's standardized oral administration and efficient absorption.


Q: How does paracetamol compare to aspirin regarding stomach irritation?

Regulatory safety warnings for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as aspirin, include a specific caution regarding the risk of stomach bleeding and irritation. This warning is related to NSAIDs, and it differs from the primary safety concerns noted for paracetamol in official product labels, which focus mainly on hepatic risk.


Q: Is there a maximum number of days paracetamol can be used continuously?

Official over-the-counter regulatory labels indicate a limit for continuous self-medication without professional guidance. This is often stated as a maximum of 10 days for pain relief or 3 days for fever.


Q: Is Albert Heijn Paracetamol suitable for people with high blood pressure?

Regulatory safety data lists hypertension (high blood pressure) as a commonly reported adverse event in some forms of paracetamol, such as the injection. This adverse event reporting confirms that changes in blood pressure are part of the documented safety profile, but hypertension is not listed as a general contraindication for the oral form.


Q: How quickly should I expect Albert Heijn Paracetamol to start working?

Patient information aligned with regulatory sources indicates that the effect is expected to begin within approximately half an hour to one hour after administration.


Q: How long does the effect of Albert Heijn Paracetamol typically last?

Official pharmacological texts state that the plasma elimination half-life is typically 2 to 3 hours in adults. The effect is generally described as lasting for several hours. The regulatory dosing protocol governs the time separation between subsequent administrations.


Q: Does Albert Heijn Paracetamol have a different effect than other brands of paracetamol?

Regulatory documents detail the mechanism of action and safety profile of the active ingredient, paracetamol (acetaminophen), itself. These core properties are established based on the active ingredient and regulatory documents indicate consistency across products containing the same substance.


Q: Can paracetamol cause drowsiness or sleepiness?

Adverse reaction data lists somnolence, which is a state of drowsiness or sleepiness, as a very rare effect in some formulations. This confirms it as a documented, though uncommon, possibility.


Q: Are there any specific foods or drinks to avoid when taking paracetamol?

Official warnings specifically caution against the chronic consumption of three or more alcoholic drinks per day while taking paracetamol. This combination is officially stated to increase the risk of severe liver damage. Regulatory documents do not generally prohibit specific common foods or non-alcoholic drinks.


Q: What pain relief ingredients should I look out for that interact with paracetamol?

Official documents include a strict caution against using paracetamol with any other pain or cold product that also contains acetaminophen (paracetamol). This is a primary regulatory concern regarding the high risk of exceeding the safe daily limit and causing liver damage.


Q: Are there different strengths of Albert Heijn Paracetamol available?

Paracetamol is officially approved and available in a variety of strengths and forms, including 500 mg tablets, as well as capsules and liquid suspensions. The range of strengths marketed under a specific brand is subject to the product's local regulatory market approvals.


Q: Why do some people experience nausea after taking paracetamol?

Nausea and vomiting are confirmed and documented as adverse reactions in the regulatory safety profile of paracetamol. While regulatory texts confirm the occurrence of nausea, they do not provide a detailed physiological explanation for why some individuals experience this specific side effect.


Q: What are the official warnings listed for paracetamol on product packaging?

Regulatory requirements define the key safety warnings that must be included on product packaging. These typically emphasize the risk of liver damage if the maximum daily dose is exceeded, the risk of serious skin reactions, and the importance of checking other medicines for acetaminophen content.


Q: Can paracetamol interfere with the results of certain medical tests?

Regulatory documents note that the presence of paracetamol in the body can interfere with the results of some medical and laboratory tests. This interference has been noted in specific types of laboratory tests, including those used to measure blood glucose levels.


Q: Does paracetamol interact with common supplements like multivitamins?

Regulatory-aligned patient information indicates that paracetamol is generally not affected by common dietary supplements or herbal remedies. However, regulatory standards for supplements are different from those applied to prescription or over-the-counter medicines.


Q: Can I use paracetamol if I am diabetic?

Official warnings exist regarding paracetamol's potential to interfere with the results of certain blood glucose tests. This documented possibility may affect the accuracy of monitoring results.


Q: Do regulatory bodies classify paracetamol as a highly safe over-the-counter drug?

Paracetamol is formally classified by regulatory bodies as an over-the-counter (OTC) medicine. Official safety profiles indicate that it is generally well-tolerated when used at the recommended therapeutic doses, but regulatory documents consistently emphasize the serious risk of liver damage if the maximum dose is exceeded.


Q: Can paracetamol cause changes in blood pressure?

Regulatory safety data reports both hypertension (high blood pressure) and hypotension (low blood pressure) as common adverse events for certain paracetamol formulations. These changes are part of the documented safety profile.


Q: What is the standard regulatory message about taking paracetamol when unsure about other conditions?

Regulatory labels provide a standardized instruction that if symptoms persist, worsen, or if new symptoms develop, use of the medicine should be stopped and a medical professional consulted.

Advertisements

How should Albert Heijn Paracetamol be stored and disposed of?

How to Store and Dispose of Albert Heijn Paracetamol?

Storage Conditions

Regulatory documents mandate that the medicine be stored out of the sight and reach of children.

Specific formulations, such as the soft capsules, require storage below 30°C and must be kept in the original container to protect against moisture and maintain stability. The product must not be used after the expiry date (EXP) printed on the packaging.

Disposal Instructions

Expired or unused Albert Heijn Paracetamol must be handled as pharmaceutical waste. It must not be flushed down the sink or the toilet and must not be thrown away in the rubbish bin. The official procedure requires individuals to ask a pharmacist how to properly dispose of the medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Albert Heijn Paracetamol found in:

A-Z Index: